Schedule 13G ownership disclosure
CB Pharma Acquisition Corp.
Security class unavailable · CUSIP: G2029P100
Event date: 2014-12-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 69,300
- Percent of class
- 1.2800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-14-004664
- Form type
- SC 13G
- Filer
- Origo Acquisition Corp
- CIK
- CIK 1619551
- Filed
- Dec 23, 2014
- Reporting period
- Dec 12, 2014
- Description
- Schedule 13G beneficial ownership